<DOC>
	<DOCNO>NCT01868711</DOCNO>
	<brief_summary>Psychological mindedness ( PM ) meta cognitive process person use cognitive affective ability well understand thought , feeling , behavior interact internal experience external experience world , dynamically modify behavior move towards self actualization , manner positive world . We investigate whether assessment PM distinguish depress patient benefit CBT .</brief_summary>
	<brief_title>Cognitive Behavior Therapy Depression Depression</brief_title>
	<detailed_description>Cognitive Behavior Therapy ( CBT ) find effective psychotherapy depression . Yet , effective 40 % depressed people receive treatment . Until day method predict help among depressed patient CBT . In study examine whether level psychological mindedness predict may benefit CBT among depressed patient . Subjects find clinically depressed give 14 session CBT . The screening procedure study include 20-30 minute telephone in-person interview . Clinical staff member train diagnostic interviewing conduct initial phone interview determine likely diagnostic suitability . If subject deem preliminarily eligible participation , mean clinically depress , invite in-person psychiatric evaluation conduct Depression Evaluation Services New York State Psychiatric Institute . Upon arrival subject read Depression Evaluation Services consent form evaluation.Questions answer consent offer read sign , agreeable . The evaluation include clinical interview , structure clinical interview ( SCID-IV ) , collection blood sample routine medical test , include thyroid function test , urine sample [ urine analysis toxicology screen ] . Important note : subject enroll study need take psychiatric medication must medications 3 month dose 4 week . During psychotherapy , patient continue see physician medication . Medication management NOT within province protocol . During study ongoing consultation outside physician , particularly regard change medication and/or dosage . Should MD patient decide make alternation use medication , affect patient 's participation psychotherapy study . Subjects find eligible study return within two week evaluation visit . An evaluator rate HDRS-17 CG I-Severity.If still eligible , ask sign study consent form , study explain , include risk possible benefit , well alternative voluntary nature . Once sign consent form , patient complete battery self-report instrument . Also interview clinician structured clinical interview PM . After schedule weekly CBT session study therapist . During 14 week clinically monitor Beck Depression Inventory begin every session HDRS-17 every four week . They complete study measure week 8 14 week session . Study participant remit ( end treatment HDRS-17 &gt; 7 ) end CBT trial offer medication three month receive referral alternative psychotherapy , per patient 's preference .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Males female age 18 70 ( inclusive ) . Primary DSMIVTR diagnosis major depression A negative urine toxicology , i.e. , urine specimen test positive use drug abuse , use benzodiazepine . Ability give inform consent . Fluent English Patients `` lifetime '' history Schizophrenia current psychotic disorder , Major Depressive Disorder Psychotic Catatonic feature , Bipolar I Affective Disorder Organic Mental Disease . DSMV substance abuse dependence within past 6 month ( except nicotine caffeine ) . Active suicidal homicidal ideation , judge serious suicide risk . Any unstable medical neurological condition . Presently receive psychotherapy . Prior History CBT Depression treatment failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Cognitive Behavior Therapy</keyword>
	<keyword>Psychological Mindedness</keyword>
</DOC>